Prospective Study of Clinical Utility of Acupuncture in Back Pain
PUCTURE-CV
Prospective Epidemiological Study To Evaluate The Clinical Utility Of Acupuncture In The Treatment Of Back Pain (Study PUCTURE-CV)
1 other identifier
observational
102
1 country
1
Brief Summary
The purpose of this study is to evaluate prospectively the effectiveness of acupuncture as adjunctive therapy in the treatment of spinal pain is the three backbone areas: cervical, thoracic and lumbar pain, under conditions of usual clinical practice as the medical acupuncturist performed acupuncture, with and without supplementary pharmacological treatment during the first 4 weeks of follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 28, 2010
CompletedFirst Posted
Study publicly available on registry
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedNovember 8, 2011
November 1, 2011
1.9 years
September 28, 2010
November 7, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VAS: Visual Analogic Scale of pain
Pain assesment will be evaluated using a Visual Analogic Scale of pain (VAS). This variable will be evaluated in all 10 visits and it will be showed its evolution (decrease) along the study
10 weekly visits
Secondary Outcomes (5)
Sheehan Disability Questionnaire
First Visit (week 1) and Final Visit (week 10)
Evaluation of the Scale Hospital Anxiety Depression (HAD)
First Visit (week 1) and Final Visit (week 10)
Health Questionnaire EuroQol-5D
First Visit (week 1) and Final Visit (week 10)
Assessment of sleep with the integrated scale MOS (Medical Outcomes Study)
First Visit (week 1) and Final Visit (week 10)
McGill Pain Questionnaire
10 weekly visits
Study Arms (2)
With usual concomitant treatment
Two observational cohorts of patients will be evaluated: with and without concomitant analgesic/ antiinflammatory drugs. The objective is evaluate that both therapies (drugs and acupuncture) could be used as adjunctive therapy in order to maximize the analgesia that could be reached
Without usual concomitant treatment
This group include patients that are not been treated with analgesic drugs at the beginning of the study. As an observational and naturalistic study any indicated treatment is allowed in any time
Eligibility Criteria
The study population is patients who go to the Acupuncture Office diagnosed of cervical, thoracic or lumbar pain caused by musculoskeletal diseases, pretreated with pharmacological treatment, they start treatment with acupuncture as adjunctive therapy for symptoms of their disease. Initially it was estimated that the optimal number of patients included to achieve the objectives of the study is 102 patients
You may qualify if:
- Patients of both sexes, aged 18 and over
- Patients diagnosed with back pain: cervical, thoracic or lumbar.
- Patients who has received appropriate medical treatment for their disease: analgesics, anti-inflammatories, or other treatments, but painful and symptoms persist
- Patients that could receive acupuncture treatment in order to reduce the symptoms and reviewed by a medical acupuncturist
- Patients with sufficient cultural and educational level to complete the health questionnaires required in the study
- Patients who have given their written informed consent to participate in the study
You may not qualify if:
- Patient with any illness and that medical opinions recommended not to participate in the study
- Patient can not respond to questionnaires administered during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Group G-6lead
Study Sites (1)
I.H. Hospital San Jose
Madrid, Madrid, 20010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valentin Martin, MD, PhD
Grupo G6
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2010
First Posted
November 1, 2010
Study Start
July 1, 2010
Primary Completion
June 1, 2012
Study Completion
October 1, 2012
Last Updated
November 8, 2011
Record last verified: 2011-11